Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group.

Koenig BA, Greely HT, McConnell LM, Silverberg HL, Raffin TA.

J Womens Health. 1998 Jun;7(5):531-45. No abstract available.

PMID:
9650154
2.
3.

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.

Schoumacher F, Glaus A, Mueller H, Eppenberger U, Bolliger B, Senn HJ.

Swiss Med Wkly. 2001 Apr 21;131(15-16):223-6.

4.

Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.

[No authors listed]

Ann Intern Med. 2014 Feb 18;160(4):I-16. doi: 10.7326/P14-9008. No abstract available.

PMID:
24366402
5.

[Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].

Schmutzler RK, Kempe A, Kiechle M, Beckmann MW.

Dtsch Med Wochenschr. 1999 May 7;124(18):563-6. Review. German. No abstract available.

PMID:
10356583
6.

Breast & ovarian cancer. Issues in risk assessment.

Caro SW.

Adv Nurse Pract. 1999 Aug;7(8):26-32; quiz 33-4. Review. No abstract available.

PMID:
10745719
7.
8.

Genetic tests forge ahead, despite scientific concerns.

Marshall A.

Nat Biotechnol. 1996 Dec;14(13):1642-3. No abstract available.

PMID:
9634835
9.

Clinical implications of BRCA1 genetic testing.

Dørum A, Heimdal K, Møller P.

Acta Obstet Gynecol Scand. 1998 Apr;77(4):458-61. No abstract available.

PMID:
9598958
10.

Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.

Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J.

Gynecol Oncol. 1998 Sep;70(3):432-4.

PMID:
9790802
11.

Genetic counseling for BRCA1/BRCA2 testing.

Schneider KA.

Genet Test. 1997;1(2):91-8.

PMID:
10464632
12.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

PMID:
11192759
13.

Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

Heisey RE, Carroll JC, Warner E, McCready DR, Goel V.

Can Fam Physician. 1999 Jan;45:114-24. Review.

14.

A public health perspective on the control of predictive screening for breast cancer.

Cunningham GC.

Health Matrix Clevel. 1997 Winter;7(1):31-48. No abstract available.

PMID:
10167177
15.

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.

Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A.

J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23.

17.

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Burke W, Daly M, Garber J, Botkin J, Kahn MJ, Lynch P, McTiernan A, Offit K, Perlman J, Petersen G, Thomson E, Varricchio C.

JAMA. 1997 Mar 26;277(12):997-1003. Review.

PMID:
9091675
18.

Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.

Shulman LP.

Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Review.

PMID:
20494261
19.
20.

Coming to grips with genes and risk.

Kahn P.

Science. 1996 Oct 25;274(5287):496-8. No abstract available.

PMID:
8928001
Items per page

Supplemental Content

Support Center